Metformin is a novel suppressor for transforming growth factor (TGF)-β1

Metformin is a widely used first-line antidiabetic drug that has been shown to protect against a variety of specific diseases in addition to diabetes, including cardiovascular disorders, polycystic ovary syndrome, and cancer. However, the precise mechanisms underlying the diverse therapeutic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Han, Zhang, Jianshu, Xu, Zhonghe, Feng, Yenan, Zhang, Mingliang, Liu, Jianli, Chen, Ruifei, Shen, Jing, Wu, Jimin, Lu, Zhizhen, Fang, Xiaohong, Li, Jingyuan, Zhang, Youyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923858/
https://www.ncbi.nlm.nih.gov/pubmed/27349853
http://dx.doi.org/10.1038/srep28597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923858/
https://www.ncbi.nlm.nih.gov/pubmed/27349853
http://dx.doi.org/10.1038/srep28597

Ejemplares similares